Clinical management of cystic echinococcosis: state of the art, problems, and perspectives.
Clinical management of cystic echinococcosis (CE) has evolved over decades without adequate evaluation of important features such as efficacy, effectiveness, rate of adverse reactions, relapse rate, and cost. CE occurs in health care environments as different as Europe/North America and resource-poor countries of the South and the East. This creates setting-specific problems in the management of patients. Furthermore, studies carried out in either of the two fundamentally different environments lack external validity, i.e., results obtained in one setting may be different from those in the other and practices that can work in one may not be applicable to the other. In this paper, we review the current management procedures of CE with particular emphasis on the evidence base and setting-specific problems.
Junghanss
Thomas
T
Section of Clinical Tropical Medicine, University Hospital Heidelberg, Heidelberg, Germany. thomas.junghanss@urz.uni-heidelberg.de
da Silva
Antonio Menezes
AM
Horton
John
J
Chiodini
Peter L
PL
Brunetti
Enrico
E
D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use; D004443:Echinococcosis / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*; D019317:Evidence-Based Medicine; D006801:Humans
D000871:Anthelmintics